Catalyst Wire Dossier Catalyst Wire Dossier

EnvSeq-1

EnvSeq-1 immunogen · NIAID
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EnvSeq-1, covering 2023-02-01 to 2023-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults [Phase 1]

See pricing